GSK3B and cardiac hypertrophy: Zhang et al. recently found that miR-26 is significantly reduced in a rat cardiac hypertrophy model and may regulate physiological structural changes of rat hearts by targeting glycogen synthase kinase 3 β (GSK3β) [65].